WLYB
JOHN WILEY & SONS, INC.
$43.29
-1.61%
$2.3B
No data for this timeframe.
Vol
Market Cap$2.3B
Cap SizeMid Cap
Inst. Holders4 funds
Inst. Value$3.1M
Inst. Activity2 buys / 0 sells
SEC Reports2
Exchange NYSE·Sector Books: Publishing or Publishing & Printing·Inc. NY·CIK 0000107140·Prev Close $44.00
Recent Activity
Jun 2, 2026
SEC
Wiley completed the all-cash acquisition of Emerald Publishing for £337.5M ($452M), funded from cash on hand. The acquis
8-K — Impact 7/10
May 6, 2026
SEC
Wiley announced the departure of Jay Flynn, EVP and GM of Research and Learning, and the appointment of Jessica Kowalski
8-K — Impact 2/10
Inst.
VANGUARD GROUP INC — ADD
34,092 shares ($1.1M)
Inst.
BANK OF AMERICA CORP — DOUBLED
62 shares ($1.9K)
Analyst Ratings
1Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $2.0M | TRIM |
| VANGUARD GROUP INC | $1.1M | ADD |
| BANK OF AMERICA CORP | $1.9K | DOUBLED |
| WELLS FARGO & COMPANY/MN | $11.00 | — |
4 institutional holders with $3.1M total value (99,160 shares) as of 2025-Q4. Top holders: MORGAN, VANGUARD, BANK. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 65,006 | $2.0M | 64.9% | TRIM -55.4% |
| 2 | VANGUARD GROUP INC | 34,092 | $1.1M | 35.1% | ADD +93.6% |
| 3 | BANK OF AMERICA CORP /DE/ | 62 | $1.9K | 0.1% | DOUBLED +785.7% |
| 4 | WELLS FARGO & COMPANY/MN | — | $11.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | ADD | 17,611 | 34,092 | +93.6% | $1.1M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 7 | 62 | +785.7% | $1.9K | 2025-Q4 |
| VANGUARD GROUP INC | DOUBLED | 6,415 | 17,611 | +174.5% | $795.0K | 2025-Q2 |
| UBS Group AG | TRIM | 6,335 | 4,335 | -31.6% | $195.7K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 145,704 | 65,006 | -55.4% | $2.9M | 2025-Q1 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 4.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 80% buy across 5 analysts — 1 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-04-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.5B | 1.7% | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-04-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.7B | 0.1% | — |
| Next FY 2027-04-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.7B | 2.3% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| May 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Apr 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Mar 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Feb 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% | |
| Jan 1, 2026 | 1 | 3 | 1 | 0 | 0 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.